Update of phase I study of imatinib (STI571) in advanced soft tissue sarcomas and gastrointestinal stromal tumors: a report of the EORTC Soft Tissue and Bone Sarcoma Group.

European journal of cancer (Oxford, England : 1990)

Volumn 38 Suppl 5, Issue , 2002, Pages

  van Oosterom, Allan T ^a   Judson, Ian R ^a   Verweij, Jaap ^a   Stroobants, Sigrid ^a   Dumez, Herlinde ^a   Donato di Paola, Eugenio ^a   Sciot, Raf ^a   Van Glabbeke, Martine ^a   Dimitrijevic, Sasa ^a   Nielsen, Ole S ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ENZYME INHIBITOR; IMATINIB; PIPERAZINE DERIVATIVE; PYRIMIDINE DERIVATIVE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONNECTIVE TISSUE TUMOR; DOSE RESPONSE; FEMALE; GASTROINTESTINAL TUMOR; HUMAN; MALE; MAXIMUM TOLERATED DOSE; MIDDLE AGED; MULTICENTER STUDY; PHASE 1 CLINICAL TRIAL; SARCOMA; STROMA CELL; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; MALE; MAXIMUM TOLERATED DOSE; MIDDLE AGED; NEOPLASMS, CONNECTIVE TISSUE; PIPERAZINES; PYRIMIDINES; SARCOMA; STROMAL CELLS; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 0036769721     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0959-8049(02)80608-6     Document Type: Article

References (0)